MOLOGEN AG (ISIN DE0006637200) has closed the fiscal year with financial figures characteristic for a biotech enterprise with a focus on research. The preparatory work and measures implemented over the past months, the latest developments, and a further improved financial situation with better liquidity form a solid basis for MOLOGEN’s positive economic and operational development in 2006.
